• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation

By: Johnson Fistel, LLP via Business Wire
October 14, 2023 at 11:19 AM EDT

Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Morphic Holding, Inc. (NASDAQ: MORF), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

What if I purchased Morphic securities? If you purchased securities and suffered significant losses on your investment, join our investigation now:

https://www.johnsonfistel.com/investigations/morphic-holding

Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471

There is no cost or obligation to you.

What is Johnson Fistel investigating? Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer.

In September of 2023, the company released details of its 12-week treatment of severe ulcerative colitis. The results demonstrated that 25.7% of patients who received their treatment showed endoscopic improvement. Following this news, the stock plummeted 55%.

What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at (619) 814-4471 or jimb@johnsonfistel.com.

About Johnson Fistel, LLP:

Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Attorney advertising.

Past results do not guarantee future outcomes.

Services may be performed by attorneys in any of our offices.

Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231014711112/en/

Contacts

Johnson Fistel, LLP

James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471

jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News

View More
Why Vertical Aerospace Stock Could Double After This Flight Test
Today 17:24 EST
Via MarketBeat
Tickers AAL EVTL VTOL
Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Today 16:40 EST
Via MarketBeat
Tickers AMZN
AI Stocks Are Surging—But Volatility Could Be the Next Big Test
Today 16:37 EST
Via MarketBeat
Topics Artificial Intelligence
Tickers AAPL COST GOOGL MSFT
Seagate's Record Earnings Prove Its Role as a Core AI Player
Today 15:42 EST
Via MarketBeat
Topics Artificial Intelligence
Tickers STX
DuPont's Spinoff Unlocks 2 Paths to Profit
Today 15:16 EST
Via MarketBeat
Tickers DD Q

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.20
+0.88 (0.35%)
AAPL  270.14
+0.10 (0.04%)
AMD  256.33
+6.28 (2.51%)
BAC  52.45
-1.09 (-2.04%)
GOOG  284.75
+6.69 (2.41%)
META  635.95
+8.63 (1.38%)
MSFT  507.16
-7.17 (-1.39%)
NVDA  195.21
-3.48 (-1.75%)
ORCL  250.31
+2.14 (0.86%)
TSLA  462.07
+17.81 (4.01%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap